Skip to main content
  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
      • Research Guidelines
        • Minimum Information About Microarray Data Experiments (MIAME)
      • Abstract
      • Acknowledgments
      • Clinical Implications (Only by invitation)
      • Conflict(s) of Interest/Disclosure(s) Statement
      • Figure Legends
      • Figures
      • Novelty and Significance: 1) What Is New, 2) What Is Relevant?
      • References
      • Sources of Funding
      • Tables
      • Text
      • Title Page
      • Online/Data Supplement
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
      • Change of Authorship Form
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
  • Facebook
  • Twitter

  • My alerts
  • Sign In
  • Join

  • Advanced search

Header Publisher Menu

  • American Heart Association
  • Science Volunteer
  • Warning Signs
  • Advanced Search
  • Donate

Hypertension

  • My alerts
  • Sign In
  • Join

  • Facebook
  • Twitter
  • Home
  • About this Journal
    • General Statistics
    • Editorial Board
    • Editors
    • Information for Advertisers
    • Author Reprints
    • Commercial Reprints
    • Customer Service and Ordering Information
  • All Issues
  • Subjects
    • All Subjects
    • Arrhythmia and Electrophysiology
    • Basic, Translational, and Clinical Research
    • Critical Care and Resuscitation
    • Epidemiology, Lifestyle, and Prevention
    • Genetics
    • Heart Failure and Cardiac Disease
    • Hypertension
    • Imaging and Diagnostic Testing
    • Intervention, Surgery, Transplantation
    • Quality and Outcomes
    • Stroke
    • Vascular Disease
  • Browse Features
    • AHA Guidelines and Statements
    • Acknowledgment of Reviewers
    • Clinical Implications
    • Clinical-Pathological Conferences
    • Controversies in Hypertension
    • Editors' Picks
    • Guidelines Debate
    • Meeting Abstracts
    • Recent Advances in Hypertension
    • SPRINT Trial: the Conversation Continues
  • Resources
    • Instructions to Reviewers
    • Instructions for Authors
    • →Article Types
    • → Submission Guidelines
    • →Tips for Easier Manuscript Submission
    • → General Instructions for Revised Manuscripts
    • → Costs to Authors
    • → Open Access, Repositories, & Author Rights Q&A
    • Permissions to Reprint Figures and Tables
    • Journal Policies
    • Scientific Councils
    • AHA Journals RSS Feeds
    • International Users
    • AHA Newsroom
  • AHA Journals
    • AHA Journals Home
    • Arteriosclerosis, Thrombosis, and Vascular Biology (ATVB)
    • Circulation
    • → Circ: Arrhythmia and Electrophysiology
    • → Circ: Cardiovascular Genetics
    • → Circ: Cardiovascular Imaging
    • → Circ: Cardiovascular Interventions
    • → Circ: Cardiovascular Quality & Outcomes
    • → Circ: Heart Failure
    • Circulation Research
    • Hypertension
    • Stroke
    • Journal of the American Heart Association
Scientific Contributions

Trajectory of Psychological Risk and Incident Hypertension in Middle-Aged Women

Katri Räikkönen, Karen A. Matthews, Lewis H. Kuller
Download PDF
Hypertension. 2001;38:798-802
Originally published October 1, 2001
Katri Räikkönen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Karen A. Matthews
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lewis H. Kuller
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Tables
  • Info & Metrics
  • eLetters

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters
Loading

Abstract

The aim of the study was to test the hypotheses that the trajectory of psychological risk (ie, persistent or increasing measures of depression and anxiety symptoms, anger, and low social support over time) increases the risk for the development of hypertension and that blood pressure levels fluctuate with psychological changes in women. Initially, healthy normotensive middle-aged women (n=541; 90.6% white, 8.9% African American) were followed across an average of 9.2 years of follow-up. Psychological characteristics were assessed repeatedly via standardized questionnaires, and Cox proportional hazards and random regression models were used to analyze their impact, adjusting for hypertension risk factors (age, race, years of education, parental history of hypertension, baseline blood pressure, body mass index, physical activity, alcohol use, and cigarette smoking). Seventy-five women became hypertensive during the follow-up period. Baseline levels of depression, anxiety, anger, and social support did not predict subsequent hypertension. A high level of anxiety throughout the follow-up, an increase in the level of feelings of anger, and a decrease in the level of social support over the follow-up were significant predictors of hypertension incidence (all P<0.05), although covariate adjustment reduced some of the significance levels to nonsignificance. In women, increases in depressive symptoms were significantly associated (P=0.003) with concurrent increases in the level of systolic blood pressure, especially among hypertensive patients (P=0.0001). Increasing levels of anger, decreasing levels of social support, and high anxiety increase the likelihood of women’s development of hypertension in midlife. These results emphasize the importance of evaluating the trajectory of psychological risk during the period of evolving hypertension.

  • blood pressure
  • risk factors
  • stress, mental
  • age
  • women
  • depression
  • anxiety
  • hostility

Risk for hypertension is linked to several psychosocial factors. In particular, symptoms of depression and/or anxiety predicted a 1.59- to 3.24-fold increase in risk for hypertension development across 5 to 20 years.1–3 However, these results were not consistent across age groups,1 race,1,2 gender,3,4 and site,4 and Goldberg et al5 reported no relation of antecedent depressive symptoms to hypertension across a follow-up of 2 months to 3 years.

The above studies reported the associations of a single measure of symptoms of depression and anxiety and hypertension measured from 2 months to 20 years later. Because the levels of depression and anxiety were not necessarily persistent throughout the follow-up interval,6 the lack of association between symptoms of depression, anxiety, and hypertension may reflect a lack of stability in psychological symptoms. That is, some individuals may experience a trajectory of increased psychological risk, ie, an increase in symptoms over time, whereas others may experience a trajectory of decreased psychological risk, ie, a decrease in symptoms over time. Accordingly, we examined the association between trajectories of self-reported symptoms of depression and anxiety on the basis of repeated symptom assessments across an average of 9.2 years of follow-up and hypertension incidence in middle-aged women participating in the Healthy Women Study (HWS), Pittsburgh, Pa.7,8 The availability of multiple measurements also enabled the examination of whether changes in symptoms of depression and anxiety that a woman experienced across the 9 years would covary with changes in her blood pressure (BP) level, on a within-woman basis. We anticipated that the BP of hypertensives would be particularly responsive to changes in the psychological symptoms.

We previously reported that increasing anger over 3 years was associated with a concurrent increase in the level of BP in the HWS.8 We extended this work by also evaluating the trajectories of angry feelings over 9 years and low social support on the development of hypertension and the covariation of anger and low social support and BP levels on a within-woman basis. Low support affects cardiovascular function.9

Methods

Subjects and Procedure

The HWS began as a prospective study of changes during the climacteric.10 In 1983 to 1984, 541 (90.6% white) participants were recruited from a driver’s license list; they were premenopausal, age 42 to 50 years, normotensive, and not taking medications that would interfere with risk-factor tracking. The Institutional Review Board at the University of Pittsburgh approved this project, and all gave informed consent. Women underwent a baseline clinical examination and reported their menstrual status monthly. Women returned periodically for follow-up exams after 12 months of no menses and at 2, 5, and 8 years after menopause. During the follow-up period (mean, 9.2 years; SD, 3.4 years; range, 1 to 14 years), 75 women were classified as hypertensive because they reported use of antihypertensive medication and/or had elevated systolic BP (SBP; ≥140 mm Hg) or diastolic BP (DBP; ≥90 mm Hg) on 2 consecutive exams. Four hundred thirty-one women remained normotensive (35 women [6.5%] had no follow-up data on BP).

Measures

BP was measured with a random-zero muddler sphygmomanometer by observers trained and certified by the Multiple Risk Factor Intervention Trial protocol.11 Three BP measures were obtained, and the last 2 were averaged. Body mass index (BMI; weight in kilograms divided by height in meters squared) was measured in the clinic. Cigarette smoking was defined as the number of cigarettes smoked per day, and alcohol intake was defined as the amount of current alcohol intake per day converted into grams of absolute alcohol (grams per day). The Paffenbarger activity questionnaire12 was used to obtain kilojoules per week spent in leisure-time activity. Parental history of hypertension was scored as yes or no.

Women completed the Beck Depression Inventory13 for depressive symptoms, Spielberger Trait Anxiety Questionnaire,14 Framingham Tension Scale,15 and the Social Anxiety Scale16 for symptoms of anxiety, Spielberger Trait Anger Scale17 for intensity and frequency of anger, and the Interpersonal Support Evaluation List18 for low social support.

Statistical Analyses

Cox proportional hazards models described the relationship between hypertension incidence and psychological characteristics measured in 3 ways: (1) baseline values only; (2) mean of observations, including baseline, before diagnosis for hypertensives and until final follow-up for normotensives; and (3) mean change from baseline to each observation before diagnosis for hypertensives and to each observation until final follow-up for normotensives.

Multilevel random coefficient regression analyses described the within-person associations of changes in psychological characteristics and changes in BP,19 with BP serving as a within-subject dependent variable and psychological characteristics serving as time-varying predictor variables. Interaction terms of hypertensive status by psychological characteristic and appropriate main effects were added to the models to test the reactivity of hypertensive patients. The maximum likelihood estimation method, with variance components covariance and spatial power residual covariance matrices, and person-centered within-person predictor data were used. Covariates were age (at baseline and menopause), race, education in years, parental history of hypertension, and baseline SBP, alcohol consumption, smoking, physical activity, and BMI. Also, duration of follow-up, BMI, and health habits were treated as time-varying covariates.

Results

Baseline characteristics and change in the study variables across the follow-up in terms of coefficients of variation for normotensive subjects and hypertensive patients are shown separately in Table 1. Individuals who became hypertensive were at baseline older, African American, and heavier and exercised less often; they had a parent(s) with a history of hypertension and exhibited higher baseline values (all, P<0.01). Menopausal age (controlling for baseline age) exhibited a negative effect on hypertension (P<0.03), reflecting that those who were older at baseline became menopausal earlier (r=−0.33, P<0.0001 between baseline and menopausal age). Multivariate analyses with baseline predictors entered simultaneously into the regression equation indicated that SBP, DBP, BMI, and parental history of hypertension remained significant independent predictors of hypertension incidence, whereas age, race, and physical activity became nonsignificant (Table 2). On the basis of these analyses, baseline SBP, BMI, and parental history of hypertension were applied as covariates in the subsequent Cox models.

View this table:
  • View inline
  • View popup
Table 1.

Baseline Characteristics for Hypertensives and Normotensives

View this table:
  • View inline
  • View popup
Table 2.

Multivariate Analyses of Biological and Health Behavior Predictors of Hypertension Incidence

Psychological Characteristics and Hypertension Incidence

Table 3 shows that none of the baseline psychological characteristics was a significant predictor of subsequent hypertension (all, P>0.10). However, hypertension incidence was predicted significantly by a higher average level of anxiety (Framingham Tension Scale, P<0.005; Social Anxiety Scale, P<0.04; Spielberger Trait Anxiety Questionnaire, P<0.06). The effect of average Framingham Tension scores on hypertension incidence remained after the covariate adjustments (all P<0.03). The effect of social anxiety remained after controlling for BMI (P=0.02) but became nonsignificant after adjustments for SBP and family history of hypertension (all P>0.06).

View this table:
  • View inline
  • View popup
Table 3.

Univariate Analyses of Psychological Predictors of Hypertension Incidence

An increase in the level of Trait Anger (P<0.03, all P>0.09 after the covariate adjustments) and a decrease in the level of social support from the baseline to the date of diagnosis predicted subsequent hypertension (P<0.01, all P<0.02 after the covariate adjustments).

To illustrate further the significant findings, relative risk for hypertension was calculated for different levels (quintiles) of average Framingham Tension scores and decreasing social support. Women with the highest tension scores (highest quintile, scores >0.47) had a 3.72-fold risk (P=0.003, 95% confidence interval [CI] 1.57 to 8.81) for developing hypertension compared with women with the lowest tension scores (lowest quintile, scores <0.04). Women whose social support scores decreased across time the most (lowest quintile, scores <−1) had a 1.81-fold risk (P=0.03, 95% CI 1.08 to 3.03) of developing hypertension compared with women whose support scores persisted across time (quintiles 2 to 4, scores from −0.83 to 1.33) and a 2.04-fold risk (P=0.09, 95% CI 0.91 to 4.58) compared with women whose support scores increased the most across time (highest quintile, scores >1.5).

Concurrent Changes in Psychological Characteristics and BP

Analyses of the within-subject covariation between concurrent changes in symptoms of depression, anxiety, and BP across the multiple data collections showed that changes in depression over time were significantly and positively associated with changes in SBP (b=0.03, t2050=3.02, P<0.003). This association was particularly true of hypertensive patients (Figure). BP did not fluctuate significantly with change in anxiety. However, changes in SBP were positively associated with changes in trait anxiety among hypertensive patients (P=0.05 for hypertensive patients, P=0.78 for normotensive subjects, F1,2045=3.77, P=0.05 for anxiety×hypertensive status interaction). Changes in anger, social support, and symptoms of distress were not significantly associated with changes in BP (all, P>0.09).

Figure1
  • Download figure
  • Open in new tab
  • Download powerpoint

Mean within-person BP levels when low in depressive symptoms (ie, 2 SD below within-person mean) and when high in depressive symptoms (ie, 2 SD above within-person mean) for normotensive subjects and hypertensive patients separately. The interaction of depressive symptoms and hypertensive status was significant for SBP and DBP (F1,2049=13.70 [P<0.0002] and F1,2049=4.14 [P<0.04], respectively), with only hypertensive patients showing an association (b=0.11 [P<0.0001] and b=0.05 [P<0.04]; all P> 0.20 for normotensive subjects).

To confirm that associations between symptoms of depression and anxiety and BP were not secondary to the effects of antihypertensive medication on symptoms (eg, see Avorn et al20 and Curb et al21), participants on medication were excluded, and the analyses were recalculated. The co-occurring fluctuation of depression and SBP remained significant in nonmedicated hypertensive patients (b=0.14, t=2.62, P<0.008), but fluctuation of trait anxiety and SBP became nonsignificant (P=0.66). Covariate adjustments did not change the significant associations (all, P<0.042), with 1 exception, the interaction between depression and hypertensive status approached conventional levels of significance in the analyses of DBP after controlling for BMI (P=0.075).

Discussion

The present study found no evidence that feeling depressed, anxious, or angry or perceiving low social support at baseline predicted incident hypertension across the lengthy follow-up period. Instead, risk of hypertension was increased among women who experienced specific trajectories: consistently high anxiety levels, increasing feelings of anger, and decreasing social support across the time period before the development of hypertension. The present results suggest that reporting distress at a single assessment may not be sufficient to have long-lasting physiological consequences. Multiple assessment may be more valuable because of the increasing reliability of measurement with more measures (with the increasing number of measures providing a more precise exposure measure) and the fact that distress has considerable variability within an individual. Ongoing psychological distress, especially that which is increasing, has particularly powerful physiological effects.

With regard to co-occurring psychological and BP changes, we found a positive association, particularly among hypertensive patients. Some investigators have proposed that large increases in BP and heart rate to psychological challenges, termed cardiovascular reactivity, are a precursor of cardiovascular diseases, including hypertension.22–24 Experimental laboratory data have reported that a depressed mood is associated with BP reactivity during acute mental stress in borderline hypertensives.25 Thus, depression may act as a vulnerability factor for high BP, particularly among those who are prehypertensive.

In addition to autonomic cardiovascular arousal, endocrine function may link depression and anxiety symptoms, anger, and low social support to hypertension.9,26 Affective disorders are hypothesized to be accompanied by noradrenergic dysregulation, the way of which may link persistent distress and hypertension. Also, depression, anxiety, anger, and low social support may operate through health-related behaviors. In the present sample, smoking, alcohol use, and physical activity were not predictive of hypertension incidence in the presence of the other hypertension risk factors. However, the risk associated with social anxiety and increasing anger was attenuated after controlling for the baseline covariates. In the within-woman analyses of BP fluctuation, neither BMI nor health behaviors eliminated the significant covariation with depression. The possible pathways need to be explored in future research.

Limitations to internal and external validity of the present study include possible bias due to unavailability of follow-up, missing data for BP or for prescription of antihypertensive medication, and psychological changes occurring between the available data points. The study participants had a different number of evaluations (range, 2 to 8 visits) across the follow-up. In consequence, individuals with more visits may have had a greater probability of exhibiting higher average anxiety levels and greater changes in depression, anger, and social support across the follow-up. However, we did examine the psychological variables according to the number of available recordings and found no evidence that the number of visits confounded the associations.

In sum, the present study provides evidence that depression and anxiety symptoms, anger, and low social support are involved in the process of evolving hypertension. However, feeling distressed at 1 point in time, 1 to 14 years before diagnosis, is not a powerful predictor of evolving hypertension. More important is the trajectory of psychological risk that the individual experiences.

Acknowledgments

This research was supported by National Institutes of Health grant HL-28266, the Pittsburgh Mind-Body Center (HL-65111 and HL-65112), and the John D. and Catherine T. MacArthur Foundation Research Network on Socioeconomic Status and Health.

  • Received November 30, 2000.
  • Revision received January 12, 2001.
  • Accepted March 16, 2001.

References

  1. ↵
    Jonas BS, Franks P, Ingram DD. Are symptoms of anxiety and depression risk factors for hypertension?: longitudinal evidence from the national health and nutrition examination survey, I: epidemiologic follow-up study. Arch Fam Med. 1997; 6: 43–49.
    OpenUrlCrossRefPubMed
  2. ↵
    Davidson K, Jonas BS, Dixon KE, Markovitz JH. Do depression symptoms predict early hypertension incidence in young adults in the CARDIA study?: coronary artery risk development in young adults. Arch Intern Med. 2000; 160: 1495–1500.
    OpenUrlCrossRefPubMed
  3. ↵
    Markowitz JH, Matthews KA, Kannel WB, Cobb JL, DeAgostino RB. Psychological predictors of hypertension in the Framingham Study. JAMA. 1993; 270: 2439–2443.
    OpenUrlCrossRefPubMed
  4. ↵
    Simonsick EM, Wallace RB, Blazer DG, Berkman LF. Depressive symptomatology and mortality in older adults. Psychosom Med. 1995; 57: 427–435.
    OpenUrlAbstract/FREE Full Text
  5. ↵
    Goldberg EL, Comstock GW, Graves CG. Psychosocial factors and blood pressure. Psychol Med. 1980; 10: 243–255.
    OpenUrlCrossRefPubMed
  6. ↵
    Blazer DG, Kessler RC, McGonagle KA, Swartz MS. The prevalence and distribution of major depression in a national community sample: the national morbidity survey. Am J Psychiatry. 1994; 151: 979–986.
    OpenUrlPubMed
  7. ↵
    Matthews KA, Wing RR, Kuller LH, Milan EN, Planting P. Influence of the perimenopause on cardiovascular risk factors and symptoms of middle-aged healthy women. Arch Intern Med. 1994; 154: 2349–2355.
    OpenUrlCrossRefPubMed
  8. ↵
    Markowitz JH, Matthews KA, Wing RR, Kuller LH, Meilahn EN. Psychological, biological and health behavior predictors of blood pressure changes in middle-aged women. J Hypertens. 1991; 9: 399–406.
    OpenUrlCrossRefPubMed
  9. ↵
    Uchino BN, Cacioppo JT, Kiecolt-Glaser JK. The relationship between social support and physiological processes: a review with emphasis on underlying mechanisms and implications for health. Psychol Bull. 1996; 119: 488–531.
    OpenUrlCrossRefPubMed
  10. ↵
    Matthews KA, Kelsey SF, Meilahn EN, Kuller LH, Wing RR. Educational attainment and behavioral and biologic risk factors for coronary heart disease in middle-aged women. Am J Epidemiol. 1989; 129: 1132–1144.
    OpenUrlAbstract/FREE Full Text
  11. ↵
    Dischinger P, Duchene AG. Quality control aspects of blood pressure measurements in the Multiple Risk Factor Intervention Trial. Control Clin Trials. 1986; 7: 137S–157S.
    OpenUrlCrossRefPubMed
  12. ↵
    Paffenbarger RS, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol. 1978; 108: 161–178.
    OpenUrlAbstract/FREE Full Text
  13. ↵
    Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry. 1961; 4: 561–571.
  14. ↵
    Spielberger CD. Manual for the State-Trait Anxiety Inventory. Palo Alto, Calif: Consulting Psychologists Press; 1983.
  15. ↵
    Haynes SG, Levine S, Scotch N, Feinleib M, Kannel WB. The relationship of psychological factors to coronary heart disease in the Framingham study, I: methods and risk factors. Am J Epidemiol. 1978; 107: 362–383.
    OpenUrlAbstract/FREE Full Text
  16. ↵
    Scheier MF, Carver CS. The self-consciousness scale: a revised version for use in general populations. J Appl Soc Psychol. 1985; 15: 687–699.
    OpenUrlCrossRef
  17. ↵
    Spielberger CD. Preliminary Manual for the State-Trait Anger Scale (STAS). Palo Alto, Calif: Consulting Psychologists Press; 1980.
  18. ↵
    Cohen S, Mermelstein R, Kamarck T, Hoberman H. Measuring the functional components of social support.In: Sarason IG, Sarason B,eds. Social Support: Theory, Research and Applications. The Hague, The Netherlands: Martinus Nijhoff; 1985: 73–94.
  19. ↵
    SAS/STAT* Software: Changes and Enhancements Through Release 6.12. Cary, NC: SAS Institute Inc; 1997.
  20. ↵
    Avorn J, Everitt DE, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. JAMA. 1986; 255: 357–360.
    OpenUrlCrossRefPubMed
  21. ↵
    Curb JD, Schneider K, Taylor JO, Maxwell M, Shulman J. Antihypertensive drug side effects in the Hypertension Detection and Follow-Up Program. Hypertension. 1988; 11(pt 2): 1151–1155.
    OpenUrl
  22. ↵
    Krantz DS, Manuck SB. Acute psychophysiologic reactivity and risk of cardiovascular disease: a review and methodologic critique. Psychol Bull. 1984; 96: 435–464.
    OpenUrlCrossRefPubMed
  23. ↵
    Matthews KA, Weiss SM, Detre T, Dembroski TM, Falkner B, Manuck SB, Williams RBJr. Handbook of Stress, Reactivity, and Cardiovascular Disease. New York, NY: John Wiley & Sons Inc; 1986.
  24. ↵
    Fredrikson M, Matthews KA. Cardiovascular responses to behavioral stress and hypertension: a meta-analytic review. Ann Behav Med. 1990; 12: 30–39.
    OpenUrlCrossRef
  25. ↵
    Waked EG, Jutai JW. Baseline and reactivity measures of blood pressure and negative affect in borderline hypertension. Physiol Behav. 1990; 47: 265–271.
    OpenUrlCrossRefPubMed
  26. ↵
    Siever LJ, Davis KL. Overview: toward a dysregulation hypothesis of depression. Am J Psychiatry. 1985; 142: 1017–1031.
    OpenUrlPubMed
View Abstract
Back to top
Previous ArticleNext Article

This Issue

Hypertension
October 2001, Volume 38, Issue 4
  • Table of Contents
Previous ArticleNext Article

Jump to

  • Article
    • Abstract
    • Methods
    • Results
    • Discussion
    • Acknowledgments
    • References
  • Figures & Tables
  • Info & Metrics
  • eLetters

Article Tools

  • Print
  • Citation Tools
    Trajectory of Psychological Risk and Incident Hypertension in Middle-Aged Women
    Katri Räikkönen, Karen A. Matthews and Lewis H. Kuller
    Hypertension. 2001;38:798-802, originally published October 1, 2001

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero
  •  Download Powerpoint
  • Article Alerts
    Log in to Email Alerts with your email address.
  • Save to my folders

Share this Article

  • Email

    Thank you for your interest in spreading the word on Hypertension.

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    Trajectory of Psychological Risk and Incident Hypertension in Middle-Aged Women
    (Your Name) has sent you a message from Hypertension
    (Your Name) thought you would like to see the Hypertension web site.
  • Share on Social Media
    Trajectory of Psychological Risk and Incident Hypertension in Middle-Aged Women
    Katri Räikkönen, Karen A. Matthews and Lewis H. Kuller
    Hypertension. 2001;38:798-802, originally published October 1, 2001
    Permalink:
    del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo

Related Articles

Cited By...

Subjects

  • Cardiology
    • Etiology
      • Hypertension
        • Hypertension

Hypertension

  • About Hypertension
  • Instructions for Authors
  • AHA CME
  • Guidelines and Statements
  • Permissions
  • Journal Policies
  • Email Alerts
  • Open Access Information
  • AHA Journals RSS
  • AHA Newsroom

Editorial Office Address:
7272 Greenville Ave.
Dallas, TX 75231
email: hypertension@heart.org

Information for:
  • Advertisers
  • Subscribers
  • Subscriber Help
  • Institutions / Librarians
  • Institutional Subscriptions FAQ
  • International Users
American Heart Association Learn and Live
National Center
7272 Greenville Ave.
Dallas, TX 75231

Customer Service

  • 1-800-AHA-USA-1
  • 1-800-242-8721
  • Local Info
  • Contact Us

About Us

Our mission is to build healthier lives, free of cardiovascular diseases and stroke. That single purpose drives all we do. The need for our work is beyond question. Find Out More about the American Heart Association

  • Careers
  • SHOP
  • Latest Heart and Stroke News
  • AHA/ASA Media Newsroom

Our Sites

  • American Heart Association
  • American Stroke Association
  • For Professionals
  • More Sites

Take Action

  • Advocate
  • Donate
  • Planned Giving
  • Volunteer

Online Communities

  • AFib Support
  • Garden Community
  • Patient Support Network
  • Professional Online Network

Follow Us:

  • Follow Circulation on Twitter
  • Visit Circulation on Facebook
  • Follow Circulation on Google Plus
  • Follow Circulation on Instagram
  • Follow Circulation on Pinterest
  • Follow Circulation on YouTube
  • Rss Feeds
  • Privacy Policy
  • Copyright
  • Ethics Policy
  • Conflict of Interest Policy
  • Linking Policy
  • Diversity
  • Careers

©2017 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. The American Heart Association is a qualified 501(c)(3) tax-exempt organization.
*Red Dress™ DHHS, Go Red™ AHA; National Wear Red Day ® is a registered trademark.

  • PUTTING PATIENTS FIRST National Health Council Standards of Excellence Certification Program
  • BBB Accredited Charity
  • Comodo Secured